Plain answers about GLP-1 medicines
Mounjaro, Wegovy and Foundayo explained in clear English. Doses, side effects, NHS access and what changes from one country to the next. Every guide links to its sources.
Popular: Mounjaro nausea Wegovy missed dose Mounjaro or Wegovy

228 guides
197 linked sources
32 country guides
Updated 11 October 2026
Pick your medicine
All medicinesMounjaro
tirzepatideLicensed in the UK for weight management and type 2 diabetes. Doses, side effects, NHS access and switching.
36 guides Weekly injectionWegovy injection
semaglutideThe weekly semaglutide pen. Dose steps from 0.25 mg, heart evidence, storage and missed doses.
38 guides Daily tabletWegovy pill
oral semaglutideThe daily semaglutide tablet. How to take it on an empty stomach and how it differs from the pen.
20 guides Daily tabletFoundayo
orforglipronThe daily non-peptide tablet with no fasting rules. UK licence, doses and precautions.
20 guidesAlso covered: Ozempic, Rybelsus, Saxenda, Trulicity and newer medicines in trials.

Day-to-day life on treatment
Food, protein, sleep, alcohol, exercise and the side effects people ask about most. Practical answers you can use this week.
- Side effects and when to get help
- Getting enough protein
- Food noise
- Weight loss plateaus
- Weight regain after stopping
Pen or tablet?
Side-by-side comparisons of the main medicines, with the trial figures and daily routine for each.
- Mounjaro vs Wegovy injection: a fair UK comparison
- Wegovy pill vs Foundayo: oral GLP-1 options in the UK
- GLP-1 injections vs tablets: what changes for you
- Ozempic vs Wegovy: semaglutide brands compared in the UK
- Saxenda vs Wegovy: daily liraglutide or weekly semaglutide
- GLP-1 medicines and other type 2 diabetes treatments
Buying or travelling abroad
Licences, prescriptions and import rules differ by country. Each guide names the regulator to check before you buy or pack your pen.


Read the trials yourself
The studies behind the headline weight loss figures: who took part, how long they ran and what the numbers mean for you.
- SURMOUNT-1 explained: tirzepatide for obesity
- STEP 1 explained: semaglutide 2.4 mg and weight loss
- SELECT explained: semaglutide and cardiovascular events
- OASIS 4 explained: oral semaglutide 25 mg for weight loss
- ATTAIN-1 explained: orforglipron and the Foundayo evidence
- SURMOUNT-5 explained: tirzepatide vs semaglutide